1. The New Decade Of Healthcare: Can WeEvolve Post-Market Platforms To Inform Coverage Decisions? FDA CMS SUMMIT • Washington, DC • December 9, 2010 Nathan White, CPC…

Slide 1Responding to the Patient’s Voice: the importance of Patient Reported Outcomes Dr. Kirstie Haywood Senior Research Fellow RCN Research Institute, School of Health…

1. Health Economics and Outcomes Research Comparative Effectiveness Research Health Economic Evaluation Economic Modeling HTA Submission Global Value Dossier Value Communications…

Slide 1 Clinical Trials for Quality of Life Endpoints in Oncology Oncology Education Session Rochester, November 1, 2005 Oncology Education Session Rochester, November 1,…

Final skin toxicity and patient‑reported outcomes results from PRIME: A randomized phase 3 study of panitumumab + FOLFOX4 for 1st‑line metastatic colorectal cancer Jean‑Yves…

* Leo Fabbri, ERS Ingela Wiklund, GSK Tim Higenbottam, Chiesi Chris Compton and Leo Fabbri, EFPIA and ERS Introduction The COPD call The Severe Asthma Call Summary and questions…

Intravenous calcium and magnesium prevents oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: Results of a phase III placebo-controlled, double-blind trial…

Final skin toxicity and patient‑reported outcomes results from PRIME: A randomized phase 3 study of panitumumab + FOLFOX4 for 1st‑line metastatic colorectal cancer Jean‑Yves…

Slide 1 Building a Community of Practice and leveraging Collaboration towards shared Innovations Jane Hsieh, Executive Director SCIKMN June 3, AM Theme 1B WRM29 â OK WRM1…